Business Stimulation™  
   
   
 
 
PORTFOLIO - current clients & investments
  Bowen Craggs & Co. advises some of the world's largest companies on their web communications strategies. Clients include corporates such as Goldman Sachs, BP, Shell, Unilever and GlaxoSmithKline as wells as organisations like the Foreign & Commonwealth Office and the World Bank. We help organisations ensure that their websites are doing the jobs they should be as well as they could be. Dan is a director & shareholder at Bowen Craggs & Co.
  Quo is distruptive digital mapping software aimed at the consumer market. Originally developed in Slovenia, Dan has helped the founders to establish a UK company (Mapyx Limited) and wrote a business plan that raised start-up funding. Dan is a director & shareholder at Mapyx.
  Foviance combines the extensive usability expertise of The Usability Company with the powerful web analytics technology of WebAbacus. Foviance is changing the way people think about the experience they deliver to users through interactive channels. Dan is a shareholder and strategic advisor at Foviance.
 
PORTFOLIO - previous clients & investments
  Dan founded and managed WebAbacus from October 2001 until November 2004 . WebAbacus is now merged with The Usability Company to create Foviance (see above).
  In Spring 2005, Dan produced the "What's New in Online Marketing" event for eConsultancy.
  Dan helped to establish this UK reseller for Maxamine (see below). WebAssure helps website owners ensure that they treat their online customers with the same care, attention and respect as they pay to all their customers. Using the latest online interaction technologies WebAssure helps businesses to protect online sales and improve their customer experiences.
  Maxamine reveals exactly what is going on behind the scenes of your Web operations providing valuable information about site quality, privacy, accessibility, risk and online visitor behavior across all Web properties. Already successful in North Amercia and Asia-Pacific, Dan helped Maxamine to establish a footprint in the UK market.
  Dan was an angel investor at Cetis from 2003 to 2005 - a period where turnover doubled. Dan chose to exit when other external investors came in.